{"id":"NCT03053440","sponsor":"BeiGene","briefTitle":"A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM)","officialTitle":"A Phase 3, Randomized, Open-Label, Multicenter Study Comparing the Efficacy and Safety of the Bruton's Tyrosine Kinase (BTK) Inhibitors BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-01-25","primaryCompletion":"2022-06-21","completion":"2022-06-21","firstPosted":"2017-02-15","resultsPosted":"2023-06-09","lastUpdate":"2024-10-26"},"enrollment":201,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Waldenström's Macroglobulinemia"],"interventions":[{"type":"DRUG","name":"BGB-3111","otherNames":["Zanubrutinib","Brukinsa"]},{"type":"DRUG","name":"Ibrutinib","otherNames":["IMBRUVICA"]}],"arms":[{"label":"Arm A : Ibrutinib","type":"EXPERIMENTAL"},{"label":"Arm B: Zanubrutinib","type":"ACTIVE_COMPARATOR"}],"summary":"This study evaluated the safety, efficacy and clinical benefit of BGB-3111 (zanubrutinib) vs ibrutinib in participants with MYD88 Mutation Waldenström's Macroglobulinemia.","primaryOutcome":{"measure":"Percentage of Participants Achieving Either a Complete Response (CR) or Very Good Partial Response (VGPR) Using an Adaptation of the Response Criteria Updated at the Sixth International Workshop on WM as Assessed by an Independent Review Committee (IRC)","timeFrame":"Up to approximately 2 years and 7 months","effectByArm":[{"arm":"Arm A: Ibrutinib","deltaMin":19.2,"sd":null},{"arm":"Arm B: Zanubrutinib","deltaMin":28.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0921"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":15},"locations":{"siteCount":58,"countries":["United States","Australia","Czechia","France","Germany","Greece","Italy","Netherlands","Poland","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["29869556","40924923","39626287","39072392","38502198","37478390"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":50,"n":98},"commonTop":["Upper respiratory tract infection","Diarrhoea","Arthralgia","Contusion","Neutropenia"]}}